109 related articles for article (PubMed ID: 32111930)
1. Lifetime risks, expected years of life lost, and cost-per-life year of esophageal cancer in Taiwan.
Lai WW; Lin CN; Chang CC; Wang JD
Sci Rep; 2020 Feb; 10(1):3722. PubMed ID: 32111930
[TBL] [Abstract][Full Text] [Related]
2. Estimation of life expectancy, loss-of-life expectancy, and lifetime healthcare expenditures for schizophrenia in Taiwan.
Lêng CH; Chou MH; Lin SH; Yang YK; Wang JD
Schizophr Res; 2016 Mar; 171(1-3):97-102. PubMed ID: 26811230
[TBL] [Abstract][Full Text] [Related]
3. Estimation of Life-Year Loss and Lifetime Costs for Different Stages of Colon Adenocarcinoma in Taiwan.
Chen PC; Lee JC; Wang JD
PLoS One; 2015; 10(7):e0133755. PubMed ID: 26207912
[TBL] [Abstract][Full Text] [Related]
4. Life Expectancy and Lifetime Health Care Expenditures for Type 1 Diabetes: A Nationwide Longitudinal Cohort of Incident Cases Followed for 14 Years.
Ou HT; Yang CY; Wang JD; Hwang JS; Wu JS
Value Health; 2016 Dec; 19(8):976-984. PubMed ID: 27987648
[TBL] [Abstract][Full Text] [Related]
5. Lifetime risks, loss of life expectancy, and health care expenditures for 19 types of cancer in Taiwan.
Wu TY; Chung CH; Lin CN; Hwang JS; Wang JD
Clin Epidemiol; 2018; 10():581-591. PubMed ID: 29872347
[TBL] [Abstract][Full Text] [Related]
6. Estimation of benefit of prevention of occupational cancer for comparative risk assessment: methods and examples.
Lee LJ; Chang YY; Liou SH; Wang JD
Occup Environ Med; 2012 Aug; 69(8):582-6. PubMed ID: 22576592
[TBL] [Abstract][Full Text] [Related]
7. Lifetime Risks, Life Expectancy, and Health Care Expenditures for Rheumatoid Arthritis: A Nationwide Cohort Followed Up From 2003 to 2016.
Chiu YM; Lu YP; Lan JL; Chen DY; Wang JD
Arthritis Rheumatol; 2021 May; 73(5):750-758. PubMed ID: 33295139
[TBL] [Abstract][Full Text] [Related]
8. Estimating Life Expectancy and Lifetime Healthcare Costs for Alzheimer's Disease in Taiwan: Does the Age of Disease Onset Matter?
Yeh TS; Wang JD; Ku LE
J Alzheimers Dis; 2020; 73(1):307-315. PubMed ID: 31771049
[TBL] [Abstract][Full Text] [Related]
9. Estimation of savings of life-years and cost from early detection of cervical cancer: a follow-up study using nationwide databases for the period 2002-2009.
Hung MC; Liu MT; Cheng YM; Wang JD
BMC Cancer; 2014 Jul; 14():505. PubMed ID: 25011933
[TBL] [Abstract][Full Text] [Related]
10. Cost-effectiveness analysis of the oral cancer screening program in Taiwan.
Huang CC; Lin CN; Chung CH; Hwang JS; Tsai ST; Wang JD
Oral Oncol; 2019 Feb; 89():59-65. PubMed ID: 30732960
[TBL] [Abstract][Full Text] [Related]
11. Cost effectiveness of cancer treatment in Taiwan.
Hung MC; Lai WW; Chen HH; Lee JC; Lin YJ; Hsiao JR; Cheng YM; Shan YS; Su WC; Wang JD
J Formos Med Assoc; 2016 Aug; 115(8):609-18. PubMed ID: 27302557
[TBL] [Abstract][Full Text] [Related]
12. Life expectancy and expected years of life lost to oral cancer in Taiwan: a nation-wide analysis of 22,024 cases followed for 10 years.
Huang CC; Ou CY; Lee WT; Hsiao JR; Tsai ST; Wang JD
Oral Oncol; 2015 Apr; 51(4):349-54. PubMed ID: 25604257
[TBL] [Abstract][Full Text] [Related]
13. Impact of work-related cancers in Taiwan-Estimation with QALY (quality-adjusted life year) and healthcare costs.
Lee LJ; Lin CK; Hung MC; Wang JD
Prev Med Rep; 2016 Dec; 4():87-93. PubMed ID: 27413666
[TBL] [Abstract][Full Text] [Related]
14. Age-standardized expected years of life lost: quantification of cancer severity.
Wang Y; Chiang CJ; Lee WC
BMC Public Health; 2019 May; 19(1):486. PubMed ID: 31046731
[TBL] [Abstract][Full Text] [Related]
15. Cost-effectiveness evaluation of mammography screening program in Taiwan: Adjusting different distributions of age and calendar year for real world data.
Lin CN; Lee KT; Chang SM; Wang JD
J Formos Med Assoc; 2022 Mar; 121(3):633-642. PubMed ID: 34246512
[TBL] [Abstract][Full Text] [Related]
16. Estimating the lifelong health impact and financial burdens of different types of lung cancer.
Yang SC; Lai WW; Su WC; Wu SY; Chen HH; Wu YL; Hung MC; Wang JD
BMC Cancer; 2013 Dec; 13():579. PubMed ID: 24308346
[TBL] [Abstract][Full Text] [Related]
17. Comparison of expected health impacts for major cancers: integration of incidence rate and loss of quality-adjusted life expectancy.
Hung MC; Lai WW; Chen HH; Su WC; Wang JD
Cancer Epidemiol; 2015 Feb; 39(1):126-32. PubMed ID: 25553846
[TBL] [Abstract][Full Text] [Related]
18. Lifetime medical expenditure and life expectancy lost attributable to smoking through major smoking related diseases in Taiwan.
Chung CW; Wang JD; Yu CF; Yang MC
Tob Control; 2007 Dec; 16(6):394-9. PubMed ID: 18048616
[TBL] [Abstract][Full Text] [Related]
19. Estimation of the financial burden to the National Health Insurance for patients with major cancers in Taiwan.
Chu PC; Hwang JS; Wang JD; Chang YY
J Formos Med Assoc; 2008 Jan; 107(1):54-63. PubMed ID: 18218578
[TBL] [Abstract][Full Text] [Related]
20. Universal health insurance, health inequality and oral cancer in Taiwan.
Wang F; Wang JD; Hung YW
PLoS One; 2018; 13(10):e0205731. PubMed ID: 30335806
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
